Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 12, Pages 468
Publisher
MDPI AG
Online
2018-11-29
DOI
10.3390/cancers10120468
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fallopian tube tumorigenesis and clinical implications for ovarian cancer risk-reduction
- (2018) Allison A. Gockley et al. CANCER TREATMENT REVIEWS
- Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation
- (2018) Joanne Kotsopoulos et al. GYNECOLOGIC ONCOLOGY
- Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations
- (2018) Denise R. Nebgen et al. GYNECOLOGIC ONCOLOGY
- Evidence of a Monoclonal Origin for Bilateral Serous Tubal Intraepithelial Neoplasia
- (2018) Emily E. Meserve et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Fallopian tube lesions in women at high risk for ovarian cancer: A multicenter study
- (2018) Kala Visvanathan et al. Cancer Prevention Research
- Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas
- (2018) Thing Rinda Soong et al. JOURNAL OF PATHOLOGY
- Tubal origin of ovarian cancer - the double-edged sword of haemoglobin
- (2017) Shiou-Fu Lin et al. JOURNAL OF PATHOLOGY
- Serous tubal intraepithelial neoplasia: the concept and its application
- (2017) Emily E K Meserve et al. MODERN PATHOLOGY
- Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
- (2017) Jennifer Ducie et al. Nature Communications
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers
- (2016) Mae Zakhour et al. GYNECOLOGIC ONCOLOGY
- Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide
- (2016) Naveena Singh et al. GYNECOLOGIC ONCOLOGY
- Haemoglobin in pelvic fluid rescues Fallopian tube epithelial cells from reactive oxygen species stress and apoptosis
- (2016) Hsuan-Shun Huang et al. JOURNAL OF PATHOLOGY
- Primary serous tubal intraepithelial carcinoma with multiple lymph node metastases
- (2016) Li-Chun Shih et al. Taiwanese Journal of Obstetrics & Gynecology
- Evidence for a Dualistic Model of High-grade Serous Carcinoma
- (2015) Brooke E. Howitt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Ovary Is an Alternative Site of Origin for High-Grade Serous Ovarian Cancer in Mice
- (2015) Jaeyeon Kim et al. ENDOCRINOLOGY
- Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesions Arising in Ovarian Serous Cystadenofibroma
- (2015) Elaine Craig et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality
- (2015) Michael S. Anglesio et al. JNCI-Journal of the National Cancer Institute
- Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality
- (2015) Michael S. Anglesio et al. JNCI-Journal of the National Cancer Institute
- Next-Generation Sequencing of Tubal Intraepithelial Carcinomas
- (2015) Andrew S. McDaniel et al. JAMA Oncology
- Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy
- (2013) C.B. Powell et al. GYNECOLOGIC ONCOLOGY
- Ovarian surface epithelium as a source of ovarian cancers: Unwarranted speculation or evidence-based hypothesis?
- (2013) Nelly Auersperg GYNECOLOGIC ONCOLOGY
- Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations
- (2013) James R. Conner et al. GYNECOLOGIC ONCOLOGY
- Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer
- (2013) Christopher P Crum et al. JOURNAL OF PATHOLOGY
- Fallopian tube precursors of ovarian low- and high-grade serous neoplasms
- (2012) Russell Vang et al. HISTOPATHOLOGY
- Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma
- (2012) Russell Vang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls
- (2010) Karishma K Mehra et al. MODERN PATHOLOGY
- Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma
- (2010) Bhavana Pothuri et al. PLoS One
- Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma
- (2009) Elke A Jarboe et al. MODERN PATHOLOGY
- The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
- (2009) Patrick O. Brown et al. PLOS MEDICINE
- Risk factors for a serous cancer precursor (“p53 signature”) in women with inherited BRCA mutations
- (2008) Aasia Saleemuddin et al. GYNECOLOGIC ONCOLOGY
- A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
- (2008) Ann K. Folkins et al. GYNECOLOGIC ONCOLOGY
- The cell of origin of ovarian epithelial tumours
- (2008) Louis Dubeau LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More